Skip to Content
Rank 1392
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address 20 FIRSTFIELD ROAD, GAITHERSBURG, MD, US

Novavax - Key figures

Market cap 4.57 Billion
Revenue 1.4 Billion
Profit -1,388,218,000
P/E Ratio No information
P/s Ratio 3.254
Buy $NVAX at eToro

Novavax - Description

Novavax, Inc., a biotechnology company, focuses on the discovery, development and commercialization of vaccines to prevent serious infectious diseases and address health needs.

The company is headquartered in Gaithersburg, Maryland.